|
Orthologous residues
|
|
YB‑1 (human): S102‑p, YB‑1 (mouse): S100‑p, YB‑1 (rat): S100‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site
|
|
Disease tissue studied:
breast cancer
|
|
Relevant cell lines - cell types - tissues:
MCF-7 (breast cell)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Akt1 (human)
|
modification site within consensus motif, co-immunoprecipitation
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|
|
Effect of modification (process):
cell growth, altered
|